scanance.
Sign inGet Premium
CL

Cellebrite DI Ltd.

CLBTTechnologyNASDAQ

Software - Infrastructure · Last scanned May 29, 2026

PriceMA150MA200
Loading chart…
End-of-day data · ScananceOpen live chart on TradingView ↗
Indicator snapshot
MA150-14.29%
$15.40

Price below medium-term moving average.

MA200-16.93%
$15.89

Below long-term trend line.

RSI-14neutral
43.9

Balanced. Not overbought, not oversold.

MACDnegative
-0.0043

Histogram negative — downward momentum.

Financials · Annual
Revenue
$475.7M
+18.6% YoY
Net Income
$78.3M
+127.7% YoY
EBITDA
$103.1M
+138.8% YoY
Free Cash Flow
$149.6M

Scan Results

Daily timeframe

1 of 4 indicators bearish as of May 28

DateIndicatorDetails
Loading...
About Cellebrite DI Ltd.

Part of the technology sector, Cellebrite DI Ltd. (CLBT) is listed under Software - Infrastructure. With a market capitalization of $3.29B, it sits in mid-cap territory. The company provides a platform of software solutions used to access, collect, review, extract, decode, decrypt, analyze, share and manage digital evidence across the investigative lifecycle for a range of investigations, such as child exploitation, homicide, anti-terror, border control, sexual crimes, organized crime, human trafficking, corporate security, and intellectual property theft, as well as financial crimes, including those involving cryptocurrency.

Key stats
Market Cap$3.29B
P/E (TTM)47.14
Fwd P/E19.97
EPS$0.28
Beta1.15
52W Change-20.9%
ROE16.4%
Analysis

Cellebrite DI Ltd. holds $429.1M in cash against $22.8M in total debt, giving it a net cash position. This means the company could theoretically pay off all its debt and still have cash remaining. The company generates $149.6M in free cash flow annually, which funds everything from R&D to shareholder returns without needing external financing. Return on equity stands at 16.4%, which is strong for the sector. ROE measures how effectively a company uses shareholder capital to generate profits. ROA of 4.8% is on the lower side, which is common in asset-heavy industries. Revenue has grown from $270.7M (2022) to $475.7M (2025), reflecting a 76% increase over the period.

With cash comfortably exceeding debt, CLBT has financial flexibility that may help navigate uncertain periods. No single metric tells the full story. Reviewing CLBT's risk profile alongside its fundamentals and technical indicators provides a more complete picture.

Links
Not financial advice. Scanance is an educational tool. Past performance does not guarantee future results.PrivacyTerms